GammaTile Insights presents new medical physics data for recurrent brain metastases from the latest GammaTile data published in Brachytherapy, August 2024. Featured speaker: Ranjini Tolakanahalli, PhD, DABR, Medical Physicist, Director of Photon Physics, Miami Cancer Institute 

Radiation oncologist Matthew Sean Peach, MD, PhD, Assistant Professor and Director of Brachytherapy Services at East Carolina University Health in Greenville, NC discusses GammaTile for Recurrent Metastases in the Oligometastatic Era.

More than 2000 patients have been treated with GammaTile. Here, co-founder Dr. David Brachman shares his thoughts on this prestigious milestone.

More than 2000 patients have been treated with GammaTile. Here, Radiation Oncologist and GammaTile Chief Medical Officer Dr. Michael Garcia shares his thoughts on this prestigious milestone.

GammaTile® Insights presents a panel of experts reviewing the latest GammaTile data published in Brachytherapy, August 2024.

Stuart Lee, MD, FACS and Sean Peach, MD, PhD present their experience using GammaTile, an innovative treatment used to treat brain tumors. This webinar was intended to educate physicians about the benefits of GammaTile.

Adam Turner, PhD, DABR presents "The Dosimetric Case for GammaTile Therapy" to educate others from a physicist's perspective.

Simon Hanft, MD, a renowned and board certified neurosurgeon specializing in treating brain tumors and complex neurosurgical conditions at Westchester Medical Center, presents "Building a Successful GammaTile Program".

In this webinar, Dr. Newton reviewed his personal experiences using GammaTile and how his patients benefited from immediate radiation, predictable dosimetry, and improved access to care. Discover the robust clinical evidence supporting the use of GammaTile® in patients with brain metastases, meningioma, and glioblastoma.

During ASTRO 2023 IET, Dr. Peach and Dr. Imber discussed the efficacy of combining surgery with GammaTile® Therapy for individuals dealing with brain metastases and high-grade recurrent Glioblastoma (GBM).